Shares shifted sharply as Ceragon Networks surged 7.64% to $2.27 ahead of this morning's second-quarter 2026 earnings release, scheduled before the market open. The company announced on July 29 that it would publish Q2 results before markets opened on August 11, 2026 , with a conference call and webcast starting at 8:30 a.m. ET . For a stock with a market cap of roughly $192 million and no trailing twelve-month profit, today's report is a decisive test of whether a flurry of contract wins can convert to bottom-line results.
• India Orders Surged to $120 Million, but Converting Bookings to Profit Is the Real Challenge
By July 28, Ceragon reported approximately $120 million in year-to-date orders from Indian operators, up from about $86 million disclosed in May.
The company recognized roughly $24 million of the earlier bookings as revenue in Q1 alone. That's impressive order growth, but the company itself warns that bookings may not convert to revenue on schedule, citing customer timing, cancellations, and macroeconomic conditions. Investors will be scanning today's report for proof that Q2 India revenue accelerated as management promised.
• Last Quarter Beat on Revenue but Margins Face Pressure
In Q1, revenue came in at $85 million versus an expected $80.36 million — a 5.77% beat — yet gross margin, while improved to 36%, came alongside
a decline in operating income to $4.2 million from $4.5 million a year earlier.
Management expects temporary margin pressure in Q2 due to a heavier India revenue mix, with recovery in Q3. Analysts are watching whether Q2 revenue hits the estimated ~$89 million and whether costs stayed in check.
• A $70 Million Asia-Pacific Deal Signals Sticky Customer Relationships
On July 21, Ceragon secured a five-year, $70 million agreement with a Tier-1 Asia-Pacific mobile operator to supply and deploy transport solutions that expand 4G and 5G network infrastructure. Multi-year contracts like this one provide recurring revenue visibility that a sub-$200 million market-cap company desperately needs.
• The Stock's Slide Into Earnings Creates a High-Stakes Moment CRNT fell from $2.30 to $2.11 over the prior week, suggesting some investors had been taking profits or hedging risk. Today's pre-earnings bounce reverses that drift entirely, pricing in confidence. Analysts maintain an average price target of $4.83 — more than double the current price — but trailing EPS of -$0.02 means the company still needs to prove it can turn a growing order book into sustained profitability. The 8:30 a.m. call will tell the story.